BR0014945A - Modificação pós-traducional de proteìnas recombinantes produzidas em plantas - Google Patents

Modificação pós-traducional de proteìnas recombinantes produzidas em plantas

Info

Publication number
BR0014945A
BR0014945A BR0014945-4A BR0014945A BR0014945A BR 0014945 A BR0014945 A BR 0014945A BR 0014945 A BR0014945 A BR 0014945A BR 0014945 A BR0014945 A BR 0014945A
Authority
BR
Brazil
Prior art keywords
plants
genetically engineered
recombinant proteins
proteins produced
posttranslational modification
Prior art date
Application number
BR0014945-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Douglas Russell
Siva Manjunath
Ronald Bassuner
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of BR0014945A publication Critical patent/BR0014945A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Peptides Or Proteins (AREA)
BR0014945-4A 1999-10-21 2000-10-20 Modificação pós-traducional de proteìnas recombinantes produzidas em plantas BR0014945A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16075899P 1999-10-21 1999-10-21
US19528200P 2000-04-07 2000-04-07
PCT/US2000/029027 WO2001029242A2 (fr) 1999-10-21 2000-10-20 Modification post-traductionnelle de proteines de recombinaison produites dans les plantes

Publications (1)

Publication Number Publication Date
BR0014945A true BR0014945A (pt) 2004-08-31

Family

ID=26857200

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014945-4A BR0014945A (pt) 1999-10-21 2000-10-20 Modificação pós-traducional de proteìnas recombinantes produzidas em plantas

Country Status (5)

Country Link
EP (1) EP1224309A2 (fr)
AU (1) AU1573601A (fr)
BR (1) BR0014945A (fr)
CA (1) CA2388432A1 (fr)
WO (1) WO2001029242A2 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
EP2264177B1 (fr) 1998-12-09 2015-09-30 Phyton Holdings, LLC Glycoproteines avec glycosilation humaine
JP4890712B2 (ja) * 1999-10-26 2012-03-07 スティヒティング ディーンスト ランドバウクンディフ オンデルズーク 植物における哺乳類型グリコシレーション
AT409381B (de) * 2000-03-03 2002-07-25 Gloessl Josef Dr Xylosyltransferase-gen
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
US7598055B2 (en) * 2000-06-28 2009-10-06 Glycofi, Inc. N-acetylglucosaminyltransferase III expression in lower eukaryotes
US7632983B2 (en) 2000-07-31 2009-12-15 Biolex Therapeutics, Inc. Expression of monoclonal antibodies in duckweed
CN100385006C (zh) 2001-01-19 2008-04-30 陶氏化学公司 利用植物细胞分泌性生产具有人型糖链的糖蛋白的方法
CA2451765A1 (fr) 2001-06-05 2002-12-12 Karen K. Oishi Expression genique et production de proteines tgf-b comprenant une substance inhibitrice mullerienne bioactive issue de vegetaux
WO2002101006A2 (fr) * 2001-06-08 2002-12-19 Icon Genetics, Inc. Production de proteines vegetales
ES2500918T3 (es) 2001-12-21 2014-10-01 Human Genome Sciences, Inc. Proteínas de fusión de albúmina e interferón beta
AU2008202355B2 (en) * 2002-03-19 2011-04-07 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants
EP2319935B1 (fr) * 2002-03-19 2016-04-27 Stichting Dienst Landbouwkundig Onderzoek Expression de GnTIII (UDP-N-acétylglucosamine: Beta -D mannoside Beta (1,4)-N-acétylglucosaminyltransferase III) dans des plantes
CA2478297C (fr) 2002-03-19 2013-05-14 Plant Research International B.V. Optimisation du traitement du glycane chez les plantes
AR042145A1 (es) 2002-11-27 2005-06-08 Dow Agrociences Llc Produccion de inmunoglobulinas en plantas con una fucocilacion reducida
US7781197B2 (en) 2002-12-20 2010-08-24 Greenovation Biotech Gmbh Transformed bryophyte cell having disrupted endogenous alpha 1,3-fucosyl and beta 1,2-xylosyl transferase encoding nucleotide sequences for the production of heterologous glycosylated proteins
EP1431394B1 (fr) * 2002-12-20 2006-08-02 greenovation Biotech GmbH Procédé de production de protéines glycosylées dans des cellules de bryophytes
WO2004067029A1 (fr) * 2002-12-27 2004-08-12 Shenzhen Tsinghua Yuanxing Bio-Pharm Science & Technology Co., Ltd. Procede de preparation d'un vaccin et vaccins antitumoraux
KR101292000B1 (ko) * 2003-01-22 2013-08-01 로슈 글리카트 아게 융합 구성체와 Ｆｃ 수용체 결합 친화도 및 이펙터 기능이증가된 항체를 생성하기 위한 이의 용도
CN100427599C (zh) * 2003-12-26 2008-10-22 吉林大学第一医院 Albsin/il－18mat杂交细胞因子
EP1809751B1 (fr) * 2004-09-29 2010-09-01 CollPlant Ltd. Collagène recombinant produit dans une plante
US8455717B2 (en) 2004-09-29 2013-06-04 Collplant Ltd. Collagen producing plants and methods of generating and using same
US8716557B2 (en) 2006-01-17 2014-05-06 Synthon Biopharmaceuticals B.V. Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plants
EP1816201A1 (fr) 2006-02-06 2007-08-08 CSL Behring GmbH Facteur de coagulation VIIa modifié ayant une stabilité 'half-life' améliorée
EP2089526B1 (fr) * 2006-11-08 2013-03-13 Centre National de la Recherche Scientifique (CNRS) Ensemble de séquences pour ciblage d'expression et contrôle des modifications post-traduction d'un polypeptide de recombinaison
CA2684370C (fr) 2007-04-17 2017-10-17 Plant Research International B.V. Glycosylation de type mammifere dans des plantes par l'expression de glycosyltransferases non mammiferes
RU2499053C2 (ru) * 2007-06-15 2013-11-20 Медикаго Инк. Способ синтеза белка с модифицированным профилем n-гликозилирования в растениях
CA2704108A1 (fr) * 2007-10-31 2009-05-07 Bayer Bioscience N.V. Procede de production de plantes modifiees a schema de n-glycosylation modifie
AU2008323811B8 (en) 2007-11-08 2014-09-18 Precision Biologics, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
ES2593277T3 (es) 2008-07-18 2016-12-07 Medicago Inc. Nuevo epítopo de inmunización contra el virus de la influenza
US20140302999A1 (en) * 2011-11-03 2014-10-09 Magdalena Leszczyniecka Method for determination of pharmacological properties of recombinant proteins
WO2014130922A1 (fr) 2013-02-25 2014-08-28 Trustees Of Boston University Compositions et procédés pour le traitement d'infections fongiques
GB201308120D0 (en) * 2013-05-06 2013-06-12 Baden Wuerttemberg Stiftung Gmbh Recombinant protein and method for its production
EP3016683B1 (fr) 2013-07-05 2020-06-24 University of Washington through its Center for Commercialization Anticorps monoclonal neutralisant la protéine mic soluble pour le traitement du cancer
WO2015050005A1 (fr) * 2013-10-02 2015-04-09 株式会社ＵｎｉＢｉｏ Composition protéique stimulant la prolifération cellulaire via le récepteur de l'egf
WO2016079739A2 (fr) 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
US20190127455A1 (en) * 2016-04-15 2019-05-02 Regenxbio Inc. Treatment of Ocular Diseases with Fully- Human Post-Translationally Modified Anti-VEGF Fab
KR102574810B1 (ko) 2016-04-15 2023-09-08 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 습성 연령 관련 황반 변성의 치료를 위한 조성물
WO2020176972A1 (fr) * 2019-03-06 2020-09-10 Plantform Corporation Vecteurs d'adn-t ayant des séquences 5' modifiées en amont d'enzymes de modification post-traductionnelles et leurs procédés d'utilisation
CA3184940A1 (fr) 2020-07-07 2022-01-13 Jennifer Donglan WU Anticorps mic et agents de liaison et leurs procedes d'utilisation
AU2022218137A1 (en) 2021-02-03 2023-08-24 Mozart Therapeutics, Inc. Binding agents and methods of using the same
TW202304524A (zh) 2021-04-10 2023-02-01 美商普方生物製藥美國公司 Folr1結合劑、其結合物及使用方法
CA3216459A1 (fr) 2021-04-23 2022-10-27 Profoundbio Us Co. Anticorps anti-cd70, leurs conjugues et leurs procedes d'utilisation
TW202320857A (zh) 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法
EP4359794A1 (fr) 2021-07-13 2024-05-01 Keystone Bio, Inc. Diagnostic pour porphyromonas gingivalis
WO2023076876A1 (fr) 2021-10-26 2023-05-04 Mozart Therapeutics, Inc. Modulation de réponses immunitaires à des vecteurs viraux
WO2023092099A1 (fr) 2021-11-19 2023-05-25 Ardeagen Corporation Agents de liaison de gpc3, leurs conjugués et leurs procédés d'utilisation
WO2024030956A2 (fr) 2022-08-03 2024-02-08 Mozart Therapeutics, Inc. Agents de liaison se liant spécifiquement à cd39 et leurs méthodes d'utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723755A (en) * 1995-05-16 1998-03-03 Francis E. Lefaivre Large scale production of human or animal proteins using plant bioreactors
DE19754622A1 (de) * 1997-12-09 1999-06-10 Antje Von Dr Schaewen Pflanzliche GntI-Sequenzen und Verwendung derselben zur Gewinnung von Pflanzen mit verminderter oder fehlender N-Acetylglucosaminyltransferase I (GnTI)-Aktivität
EP2264177B1 (fr) * 1998-12-09 2015-09-30 Phyton Holdings, LLC Glycoproteines avec glycosilation humaine
JP4890712B2 (ja) * 1999-10-26 2012-03-07 スティヒティング ディーンスト ランドバウクンディフ オンデルズーク 植物における哺乳類型グリコシレーション
WO2001031044A1 (fr) * 1999-10-26 2001-05-03 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Gonadotrophines dans les plantes

Also Published As

Publication number Publication date
CA2388432A1 (fr) 2001-04-26
EP1224309A2 (fr) 2002-07-24
WO2001029242A3 (fr) 2002-02-21
AU1573601A (en) 2001-04-30
WO2001029242A2 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
BR0014945A (pt) Modificação pós-traducional de proteìnas recombinantes produzidas em plantas
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
IL212889A0 (en) A transgenic plant comprising mammalian ??-1, 4-galactosyltransferase and ??-1, 3-glucuronyltransferase
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
BR0113864A (pt) ácidos nucléicos tipo kcp isolados e suas proteìnas codificadas
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DE69837085D1 (de) Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
DE69920747D1 (de) Methode zur herstellung von rekombinanten zellen
AR027765A1 (es) Expresion y purificacion de polipeptidos bioactivos autenticos a partir de plantas
DE69906509D1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
DE60144021D1 (de) Für zellzyklusproteine kodierende nukleinsäure und deren verwendung
DE69117123D1 (de) Menschliches MK Gen und Protein-Sequenz
NO930428L (no) Proteinstrukturen til plantetoksingelonin
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
ATE253639T1 (de) Verfahren zur herstellung von peptiden
BR0008187A (pt) Controle biológico de nematódeos
PT704527E (pt) Sequencias de adn que codificam precursores de insulina biossinteticos e processo para a preparacao de insulina
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
ATE541920T1 (de) Mit stress verbundene proteinphosphatase- polypeptide und verfahren zur verwendung in pflanzen
DE60234377D1 (de) Stress-assoziierte, protein kinase-spezifische polypeptide und verfahren zur verwendung in pflanzen
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
BR1100940A (pt) Polipeptìdeos puros, sequências adn, molécula adn recombinada, célula hospedeira, processo de manipulação genética para produção de polipeptìdeo, e, uso de um polipeptìdeo
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae
ATE103341T1 (de) Antikoerper gegen hochkonservierte aminosaeuresequenzen von immunogenen substanzen, verfahren zur herstellung dieser antikoerper, sowie deren verwendung in immunoassays.
WO2003104449A3 (fr) Ameliorations apportees a la production de proteines

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]